Indian Journal of Gynecologic Oncology

Scope & Guideline

Fostering collaboration in the fight against gynecologic cancers.

Introduction

Welcome to the Indian Journal of Gynecologic Oncology information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Indian Journal of Gynecologic Oncology, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2363-8397
PublisherSPRINGER INDIA
Support Open AccessNo
CountryIndia
TypeJournal
Convergefrom 2016 to 2024
AbbreviationINDIAN J GYNECOL ONC / Indian J. Gynecol. Oncol.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI 110 001, INDIA

Aims and Scopes

The Indian Journal of Gynecologic Oncology focuses on advancing knowledge and research in the field of gynecologic cancers, particularly in the Indian context. It encompasses a wide range of topics including clinical practices, diagnostic techniques, treatment methodologies, and the psychosocial aspects of cancer care.
  1. Gynecological Oncology Research:
    The journal publishes original research related to various gynecological cancers, including ovarian, cervical, and endometrial cancers, focusing on epidemiology, risk factors, and treatment outcomes.
  2. Clinical Practices and Treatment Outcomes:
    It highlights clinical studies assessing treatment modalities such as chemotherapy, radiotherapy, and surgical interventions, providing insights into their effectiveness and safety in treating gynecological malignancies.
  3. Innovative Diagnostic Techniques:
    The journal emphasizes advancements in diagnostic methods, including imaging techniques, biomarkers, and histopathological evaluations relevant to gynecologic cancers.
  4. Patient Quality of Life and Psychosocial Aspects:
    Research addressing the quality of life, mental health, and psychosocial issues faced by patients undergoing treatment for gynecological cancers is a critical focus area.
  5. Emerging Trends in Cancer Management:
    The journal explores novel approaches in cancer management, including fertility preservation, personalized medicine, and the use of new technologies in treatment.
Recent publications in the Indian Journal of Gynecologic Oncology indicate several emerging themes that reflect the evolving landscape of gynecologic cancer research.
  1. Fertility Preservation Techniques:
    There is a growing emphasis on research related to fertility preservation in cancer patients, reflecting increased awareness and advancements in reproductive technology.
  2. Personalized Medicine and Genomics:
    Emerging studies focus on the role of genetic markers and personalized treatment approaches in managing gynecological cancers, highlighting a trend towards tailored therapies.
  3. Telemedicine and Remote Care:
    The incorporation of telemedicine and remote monitoring in cancer care has gained attention, particularly in the context of the COVID-19 pandemic, indicating a shift in patient management strategies.
  4. Palliative Care and Quality of Life:
    An increasing number of studies are addressing palliative care approaches and their impact on the quality of life for patients suffering from advanced gynecological cancers.
  5. Integration of Artificial Intelligence in Diagnosis:
    Research exploring the application of artificial intelligence and machine learning in diagnosing and managing gynecological cancers is on the rise, indicating a technological shift in the field.

Declining or Waning

While the journal continues to cover a broad range of topics, certain areas of research appear to be losing traction or frequency in recent publications.
  1. Traditional Surgical Techniques:
    There has been a noticeable decline in publications focused solely on traditional surgical techniques without the integration of newer methodologies or technologies.
  2. Basic Epidemiological Studies:
    The frequency of basic epidemiological studies focusing on cancer prevalence and incidence without deeper analysis or intervention strategies has decreased.
  3. General Cancer Awareness Campaigns:
    Although still relevant, papers focused solely on generic cancer awareness campaigns are becoming less frequent, with a shift towards more targeted and evidence-based interventions.

Similar Journals

INTERNATIONAL JOURNAL OF HYPERTHERMIA

Driving discoveries in hyperthermia for improved patient outcomes.
Publisher: TAYLOR & FRANCIS LTDISSN: 0265-6736Frequency: 8 issues/year

INTERNATIONAL JOURNAL OF HYPERTHERMIA, published by Taylor & Francis Ltd, is a leading peer-reviewed journal dedicated to advancing the field of hyperthermia and its applications in medical science, particularly within cancer research and related disciplines. With an ISSN of 0265-6736 and an E-ISSN of 1464-5157, this journal has been a vital resource since its establishment in 1985, offering a platform for innovative research and clinical applications aimed at improving treatment outcomes. The journal is recognized with a Q2 category ranking in several fields, including Cancer Research and Physiological Medicine, reflecting its significant contribution to scientific knowledge and clinical practices. Furthermore, it has been Open Access since 2019, ensuring that cutting-edge research is accessible to a global audience. By facilitating the exchange of ideas and fostering collaborations among researchers, professionals, and students, the INTERNATIONAL JOURNAL OF HYPERTHERMIA serves as an essential resource in the quest to exploit hyperthermia’s full potential in therapeutic settings.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Elevating research in otorhinolaryngology.
Publisher: WILEYISSN: 1043-3074Frequency: 12 issues/year

HEAD AND NECK: JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, published by Wiley, is a leading academic journal dedicated to advancing the field of otorhinolaryngology. With an impressive impact factor and ranked #5 out of 123 in the field according to Scopus, this journal serves as a premier platform for researchers, clinicians, and students alike to share and gain insights into cutting-edge developments related to head and neck sciences. With publication spanning from 1989 to 2024, it enjoys a Q1 ranking in the otorhinolaryngology category, reflecting its high quality and significant contribution to the scientific community. The journal is crucial for those aiming to stay at the forefront of research and clinical practices in this highly specialized area. This combination of rigorous peer review and a focus on both practical and experimental studies make HEAD AND NECK an essential resource for anyone involved in the healthcare and research sectors pertaining to the head and neck.

Bladder Cancer

Unveiling breakthroughs in bladder cancer management.
Publisher: IOS PRESSISSN: 2352-3727Frequency: 4 issues/year

Bladder Cancer, published by IOS PRESS, is a premier open access journal dedicated to advancing the field of oncology and urology, with a specific focus on bladder cancer research and treatment. Established in 2015 and continuing through to 2024, this journal aims to disseminate high-quality, peer-reviewed research that contributes to the understanding, diagnosis, and management of bladder cancer, a critical area of concern in urological oncology. With a robust publication record now encompassing open access since 2023, Bladder Cancer ensures accessibility to vital research for clinicians, researchers, and scholars worldwide. The journal's rankings in Scopus reflect its commitment to excellence, holding a Q3 category in both oncology and urology, with Scopus ranks of #78 in Urology and #285 in Oncology, showcasing its growing influence in the scientific community. By fostering dialogue and innovation, Bladder Cancer serves as an essential resource for those committed to improving patient outcomes in bladder oncology.

Gland Surgery

Empowering the medical community through gland surgery insights.
Publisher: AME PUBLISHING COMPANYISSN: 2227-684XFrequency: 12 issues/year

Gland Surgery, an esteemed journal published by AME PUBLISHING COMPANY, is at the forefront of surgical research, particularly focusing on advancements in gland-related surgeries and their clinical implications. With an ISSN of 2227-684X and an E-ISSN of 2227-8575, this open-access journal provides a platform for disseminating high-quality research and insights into the intricate aspects of surgical practices, ranking in the Q2 category in Surgery as of 2023. As evidenced by its Scopus ranking at #153 out of 551 in the Medicine_Surgery field, Gland Surgery delivers valuable contributions to the global medical community, promoting the exchange of knowledge and innovative techniques. Operating from Hong Kong, China, and converging its excellence from 2016 to 2024, the journal is a critical resource for researchers, clinicians, and students keen on exploring the latest developments in the field. By fostering an open dialogue among professionals, Gland Surgery is accessible to a diverse audience seeking to enhance their understanding and practice in gland surgery.

Reports of Practical Oncology and Radiotherapy

Driving innovation in oncology through shared expertise.
Publisher: VIA MEDICAISSN: 1507-1367Frequency: 6 issues/year

Reports of Practical Oncology and Radiotherapy is a distinguished open-access journal dedicated to advancing the fields of oncology, radiotherapy, and cancer research. Published by VIA MEDICA since 2001, this journal serves as a critical platform for disseminating innovative research and practical findings that impact clinical practices and patient outcomes. With an emphasis on fostering collaboration and knowledge exchange among researchers, clinicians, and students, the journal has positioned itself within the Q3 and Q4 categories of renowned directories in oncology, radiology, and nuclear medicine as of 2023. Based in Gdansk, Poland, it provides unrestricted access to its articles, ensuring that crucial research reaches a wide audience. This dedication to open access reflects the journal's commitment to transparency and innovation in the fight against cancer, making it an invaluable resource in this vital field of study.

Breast Cancer

Transforming insights into impactful breast cancer solutions.
Publisher: SPRINGER JAPAN KKISSN: 1340-6868Frequency: 6 issues/year

Breast Cancer is a prestigious peer-reviewed journal published by SPRINGER JAPAN KK, specializing in the multifaceted domains of oncology and medical pharmacology. With an impressive impact factor and recognized within the Q1 category in multiple areas, including Medicine (miscellaneous), Radiology, and Nuclear Medicine and Imaging, this journal serves as a fundamental resource for cutting-edge research and clinical advancements in breast cancer treatment and care. Its indexed presence in renowned databases like Scopus further affirms its significance, ranking 56th in Radiology and 60th in Pharmacology. The journal aims to bridge the gap between clinical practice and scientific research by publishing original articles, reviews, and case studies that enhance understanding and improve patient outcomes. With converged content available from 1994 to 2024, the journal is dedicated to fostering innovative research while engaging a global audience of researchers, clinicians, and students passionate about tackling breast cancer challenges.

European Urology Oncology

Exploring the frontiers of urology and oncology for tomorrow's healthcare.
Publisher: ELSEVIERISSN: Frequency: 6 issues/year

European Urology Oncology is a premier academic journal dedicated to advancing the field of urological oncology through innovative research and interdisciplinary collaboration. Published by Elsevier and based in the Netherlands, this journal runs on the principles of providing high-quality, peer-reviewed content that meets the evolving needs of professionals in medicine, surgery, and oncology. With an impressive 2023 categorization in the Q1 quartiles across multiple disciplines including Medicine (Miscellaneous), Oncology, and Urology, the journal demonstrates its pivotal role in disseminating essential findings that enhance clinical practices. The E-ISSN of this journal is 2588-9311, ensuring accessibility to groundbreaking articles that influence treatment methodologies and patient outcomes. Researchers and professionals relying on the latest evidence in urology and oncology will find this journal essential for keeping abreast of cutting-edge developments and clinical insights that shape the future of healthcare.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY

Empowering Innovation in Women's Health
Publisher: MRE PRESSISSN: 0392-2936Frequency: 6 issues/year

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY is a pivotal publication in the field of gynecological oncology, dedicated to advancing research and clinical practices. Established in 1980 and published by MRE PRESS, this journal serves as a platform for disseminating high-quality research, reviews, and case studies pertaining to the diagnosis and treatment of gynecological cancers. Although the journal currently operates without an open access option, it remains a valuable resource for professionals seeking to stay abreast of the latest developments and findings within the field. The journal is indexed in both Scopus and other reputable databases, contributing significantly to the ongoing discourse in medicine with a particular focus on obstetrics, gynecology, and oncology, although it has seen a discontinuation in coverage by Scopus post-2021. With an emphasis on rigorous peer-review and scholarly integrity, the EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY continues to play an essential role in fostering knowledge and innovation among researchers, clinicians, and students committed to improving patient outcomes in gynecological health.

BREAST

Transforming breast cancer care through open access knowledge.
Publisher: CHURCHILL LIVINGSTONEISSN: 0960-9776Frequency: 6 issues/year

BREAST is a leading peer-reviewed journal dedicated to advancing knowledge and practice in the fields of cancer research, oncology, and surgery, published by Churchill Livingstone. With an impressive impact factor and a prestigious Q1 ranking in multiple categories including Cancer Research, Medicine, and Surgery, the journal consistently delivers high-quality content that informs and inspires researchers, clinicians, and educators. Since its transition to Open Access in 2020, BREAST has significantly expanded its reach, providing immediate and unrestricted access to pivotal studies and findings in breast health and disease management. With a history dating back to 1992 and converging to 2024, the journal serves as an essential resource for the latest developments and innovative approaches in the clinical and biomedical aspects of breast care. Scholars and professionals alike can explore a wealth of research aimed at improving patient outcomes and fostering scientific dialogue in this vital area of healthcare.

GYNECOLOGIC AND OBSTETRIC INVESTIGATION

Elevating Standards in Gynecologic and Obstetric Research
Publisher: KARGERISSN: 0378-7346Frequency: 6 issues/year

GYNECOLOGIC AND OBSTETRIC INVESTIGATION, published by KARGER, is an influential journal dedicated to advancing the fields of obstetrics and gynecology. With an ISSN of 0378-7346 and E-ISSN 1423-002X, this esteemed publication has been disseminating pivotal research since 1895 and continues to serve as an authoritative source through its convergence until 2024. Renowned for its rigorous adherence to academic standards, it stands in the Q2 category for both Obstetrics and Gynecology and Reproductive Medicine as of 2023, reflecting its quality and impact within the scientific community. With Scopus rankings highlighting its commendable positions—Rank #66 in Obstetrics and Gynecology and Rank #31 in Reproductive Medicine—it is an essential resource for researchers, professionals, and students alike, fostering a deeper understanding of women’s health issues and innovative care practices. Despite not being an open-access journal, its contributions significantly influence current and future directions in clinical and translational research.